Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion
- 1 August 1983
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 6 (4) , 305-306
- https://doi.org/10.1007/bf03347595
Abstract
The effects of the acute administration of sodium-valproate (400 mg po) on plasma ACTH levels were studied in 4 patients with Cushing’s disease, 1 with Nelson’s syndrome and in 3 with Addison’s disease. No significant reduction of corticotropin concentration was observed, as compared to saline infusion. These data do not favor the hypothesis of an inhibitory role of sodium-valproate on ACTH secretion in such patients.Keywords
This publication has 6 references indexed in Scilit:
- VALPROATE IN CUSHING'S SYNDROMEThe Lancet, 1982
- EFFECTS OF VALPROIC ACID, NALOXONE AND HYDROCORTISONE IN NELSON'S SYNDROME AND CUSHING'S DISEASEClinical Endocrinology, 1981
- EFFECT OF TREATMENT WITH SODIUM VALPROATE AND DIAZEPAM ON PLASMA CORTICOTROPIN IN NELSON'S SYNDROMEThe Lancet, 1981
- POSSIBLE ROLE OF GAMMA-AMINOBUTYRIC ACID SYNTHESIS IN THE MECHANISM OF DEXAMETHASONE FEEDBACK ACTIONJournal of Endocrinology, 1978
- BIOCHEMICAL EFFECTS IN MAN and RAT OF THREE DRUGS WHICH CAN INCREASE BRAIN GABA CONTENTJournal of Neurochemistry, 1978
- NEUROTRANSMITTER REGULATION OF CORTICOTROPIN‐RELEASING FACTOR IN VITROAnnals of the New York Academy of Sciences, 1977